Compound Library Volume I Phase 3 TRIUMPH Retatrutide Triple-receptor agonist Triple-Receptor Metabolic Peptide Retatrutide is an investigational metabolic peptide being studied for its simultaneous activity at GLP-1, GIP, and glucagon receptors
One to three months: This is the window where many people start to see a "lit-from-within" radiance
Wound healing: Accelerates repair of skin, connective tissue, and nerves
68 weeks
Studies have found that those who undergo bariatric surgery lose more weightand keep it off longerthan those who pursue other weight loss solutions
Wat beschikbaar is: Survodutide: SYNCHRONIZE-1 (primaire obesitas-uitkomst, resultaten verwacht 20252026) en SYNCHRONIZE-NASH (MASH-eindpunten, lopend) Retatrutide: TRIUMPH-1 t/m TRIUMPH-7 (obesitas, T2D, hartfalen, chronische nierziekte), waarvan TRIUMPH-1 cardiovasculaire uitkomsten als primair eindpunt gebruikt Directe vergelijking is op dit moment methodologisch niet verantwoord, omdat de fase-2-studies verschillende populaties, doseringsschemas en meetmomenten hanteerden